Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction Treatment
JAMA Network Open 10.1001/jamanetworkopen.2025.27418August 18, 2025 at 11:00 AM EDT
Do patients receiving telemedicine treatment for opioid use disorder experience barriers at the pharmacy level when filling buprenorphine prescriptions?In this cross-sectional study of 601 adults, approximately one-third of patients missed buprenorphine doses in the past 12 months due to a pharmacy-related barrier, and one-quarter experienced a challenge filling their buprenorphine prescription at the pharmacy. The most common fill barrier was that the pharmacy did not have available buprenorphine and needed to order additional stock, risking treatment interruption.This study found that challenges filling buprenorphine prescriptions were prevalent among individuals receiving telemedicine treatment for opioid use disorder, suggesting that interventions are needed to improve access to buprenorphine.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.